NASDAQ

Roivant Sciences Ltd. - Common Shares (ROIV)

♥ 597 Thanks from members

Live price chart, market sentiment, and community perspectives for Roivant Sciences Ltd. - Common Shares (NASDAQ: ROIV).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Vivek RamaswamyLeadership: Matt Gline (CEO)Holder: SoftBank Vision FundHolder: Dexcel PharmaHolder: Vanguard GroupVTAMA (tapinarof)Bimzelx (partnered)Vant Subsidiary Drug Pipelines#ROIV stock#Roivant Sciences#Biopharma Holding#Vants Model#NASDAQ ROIV